Pharmacy
Researchers say interventions collectively prevented one inappropriate prescription for every eight patients seen.
California Gov. Jerry Brown signed a sweeping drug price bill that will force drugmakers to publicly justify big price hikes.
Insurer has entered a value-based contract with Collegium Pharmaceutical for the drug Xtampza ER, an oxycodone equivalent with abuse deterrent properties.
Part of the donation will support provider education that promotes best prescribing practices for clinicians who prescribe opioid medications.
The bill, if signed by the California governor, would require drug companies to give notice to state agencies and health insurers if they plan to raise drug prices by 16 percent or more.
The PCORI-funded study will compare the effectiveness of three approaches to reducing use of the painkillers.
Mavyret's price tag of $26,400 for a course of treatment is significantly below that of other hepatitis C drugs whose sticker price ranges from about $55,000 to $95,000.
The narrative from PhRMA's publicity campaign is only the rosiest, most self-serving version of pricing say critics.
Since almost 75 percent of costs are attributable to antiretroviral drug treatment, reducing the price of those drugs could lead to even greater cost
Aegerion failed to inform providers of drug's risks outside prescribed usage, conspired to violate HIPAA, improperly distributed drug, DOJ says.